Bio-Rad Laboratories (BIO.B) to Release Earnings on Tuesday

Bio-Rad Laboratories (NYSE:BIO.B) is scheduled to release its earnings data after the market closes on Tuesday, May 7th. Investors interested in registering for the company’s conference call can do so using this link.

Bio-Rad Laboratories (NYSE:BIO.B) last released its earnings results on Thursday, February 15th. The company reported $3.10 EPS for the quarter. The firm had revenue of $681.18 million during the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%.

Bio-Rad Laboratories Stock Performance

BIO.B stock opened at $279.91 on Monday. Bio-Rad Laboratories has a twelve month low of $271.00 and a twelve month high of $467.95. The company has a quick ratio of 4.34, a current ratio of 5.83 and a debt-to-equity ratio of 0.14. The company has a market cap of $7.98 billion, a P/E ratio of -13.03 and a beta of 0.70. The business’s fifty day moving average is $320.27 and its 200-day moving average is $314.67.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.